URC:PSEUniversal Robina Corp. Analysis
Data as of 2026-06-13 - not real-time
CA$4.12
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical indicators point to a bearish short‑term outlook: the 20‑day moving average sits below both the 50‑day and 200‑day averages, the MACD line is under its signal line, and the RSI is in the lower half of its range, all of which suggest downward momentum. Volume is trending upward, but the stock is trading near a key support level while facing a resistance barrier that has held in recent sessions, and the 30‑day volatility is markedly high, amplifying price swings. Valuation metrics are mixed: the price‑to‑earnings multiple is dramatically above the sector average, yet the discounted cash‑flow model implies a substantial upside, and analyst coverage has recently upgraded the stock following the Sweetwater royalties acquisition, which broadens the royalty portfolio and adds cash‑flow stability.
Fundamental strengths and risks balance each other: the company holds a solid cash position relative to minimal debt, generates strong operating cash flow, and benefits from a diversified geographic exposure across North America, Namibia and Spain, but its earnings are modest, return on equity is low, and the uranium sector remains subject to regulatory scrutiny and commodity price volatility. The absence of a dividend underscores a growth‑oriented capital allocation strategy, while the elevated beta and high volatility signal heightened market risk, suggesting that investors should weigh the upside potential against the pronounced downside risk.
Fundamental strengths and risks balance each other: the company holds a solid cash position relative to minimal debt, generates strong operating cash flow, and benefits from a diversified geographic exposure across North America, Namibia and Spain, but its earnings are modest, return on equity is low, and the uranium sector remains subject to regulatory scrutiny and commodity price volatility. The absence of a dividend underscores a growth‑oriented capital allocation strategy, while the elevated beta and high volatility signal heightened market risk, suggesting that investors should weigh the upside potential against the pronounced downside risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish moving‑average alignment
- MACD and RSI indicating downside pressure
- Proximity to near‑term support with high volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Discounted cash‑flow upside and analyst upgrade
- Diversified royalty portfolio after Sweetwater acquisition
- Strong operating cash flow relative to debt
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term demand growth for uranium and clean‑energy transition
- Royalty model provides upside with limited capital exposure
- Solid cash reserves supporting future investments
Key Metrics & Analysis
Financial Health
Revenue Growth416400.00%
Profit Margin8.03%
P/E Ratio103.0
ROE1.29%
ROA0.43%
Debt/Equity0.04
P/B Ratio1.6
Op. Cash FlowCA$39.9M
Free Cash FlowCA$38.0M
Industry P/E21.5
Technical Analysis
TrendBearish
RSI36.7
SupportCA$3.87
ResistanceCA$5.45
MA 20CA$4.68
MA 50CA$5.01
MA 200CA$5.34
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueCA$10.33
Target PriceCA$7.65
Upside/Downside85.68%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta2.67
Volatility78.15%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.